治疗特应性皮炎的IL-4/IL-13抑制剂诱导的银屑病样皮疹转录组接近脓疱型银屑病
本文对7例度普利尤单抗诱导的银屑病样皮疹(DI-Pso)患者皮损进行基因表达谱分析,并与斑块状银屑病、特应性皮炎和健康对照(各4例)比较。结果显示DI-Pso中辅助性T细胞17/IL-23通路活化、IL-36显著表达,而辅助性T细胞2代表基因表达强烈降低,且与脓疱型银屑病上游调控因子重叠程度大于斑块状银屑病。
要点
- DI-Pso皮损中辅助性T细胞17/IL-23通路活化,IL-36显著表达。
- DI-Pso中辅助性T细胞2代表基因表达强烈降低。
- DI-Pso与脓疱型银屑病上游调控因子重叠大于斑块状银屑病。
核心结论
- DI-Pso的发病机制依赖于皮肤免疫反应从辅助性T细胞2向IL-36和辅助性T细胞17极化偏移,以及皮肤屏障改变的加剧。
研究设计与样本
- 对DI-Pso(n=7)与斑块状银屑病、特应性皮炎和健康对照(各n=4)的皮肤活检组织进行基因表达谱研究,采用富集分析和基因本体分析进行差异基因表达分析,并通过qPCR验证基因表达、免疫组化评估蛋白水平。
主要发现
- 与健康对照、斑块状银屑病和特应性皮炎皮肤相比,DI-Pso的转录组和蛋白分析显示辅助性T细胞17/IL-23通路活化,并伴有IL-36(脓疱型银屑病的替代标志物)的显著表达。
- 相比之下,DI-Pso中辅助性T细胞2代表基因的表达在所有比较中均强烈降低。
- 与脓疱型银屑病公共数据的匹配分析证实,DI-Pso与脓疱型银屑病上游调控因子重叠,且重叠程度大于与斑块状银屑病的重叠。
- 此外,与健康对照、斑块状银屑病和特应性皮炎相比,DI-Pso中许多皮肤屏障基因的表达强烈降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dupilumab is a therapeutic antibody targeting IL-4 and IL-13 receptor subunit alpha used for the treatment of patients with atopic dermatitis (AD). Cases of psoriasis-like reactions induced under dupilumab treatment (dupilumab-induced psoriatic eruption [DI-Pso]) for AD were recently reported. To understand the pathogenesis of DI-Pso, we performed gene expression profiling studies on skin biopsies of DI-Pso (n = 7) compared with those of plaque psoriasis, AD, and healthy controls (n = 4 each). Differential gene expression was performed using enrichment and Gene Ontology analysis. Gene expression was validated by qPCR, and protein levels were assessed by immunohistochemistry. Transcriptomic and protein analysis of DI-Pso compared with that of healthy controls, plaque psoriasis, and AD skins revealed activation of T helper 17/IL-23 pathways associated with a significant expression of IL-36, surrogate marker of pustular psoriasis. By contrast, T helper 2 representative genes' expression was strongly decreased in DI-Pso across comparison. Matching analysis with public data of pustular psoriasis skin corroborated that DI-Pso and pustular psoriasis upstream regulators overlap, greater than the overlap with plaque psoriasis. Furthermore, DI-Pso showed strongly decreased expression of many barrier skin genes compared with healthy controls, plaque psoriasis, and AD. Our data indicate that the pathogenesis of DI-Pso relied on a shift of skin immune responses from a T helper 2 to an IL-36 and T helper 17 polarization and on intensified skin barrier alterations.
引用
- Grolleau C, Calugareanu A, Demouche S, et al. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis. J Invest Dermatol. 2023. PMID: 36610660. doi:10.1016/j.jid.2022.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。